Activation of Notch3 in glomeruli promotes the development of rapidly progressive renal disease

Journal of the American Society of Nephrology

Volumn 26, Issue 7, 2015, Pages 1561-1575

  Machhour, Fala El ^a,b   Keuylian, Zela ^a   Kavvadas, Panagiotis ^a   Dussaule, Jean Claude ^a,b,c   Chatziantoniou, Christos ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; FIBRIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; NESTIN; NOTCH3 RECEPTOR; TRANSCRIPTION FACTOR RELA; VASCULAR CELL ADHESION MOLECULE 1; NOTCH RECEPTOR; NOTCH3 PROTEIN, MOUSE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL MIGRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOSKELETON; FIBRIN DEPOSITION; GENE DELETION; GLOMERULUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATORY INFILTRATE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY STRUCTURE; MACROPHAGE; MONOCYTE; MOUSE; NEPHROTOXICITY; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RECEPTOR UPREGULATION; RENAL PROTECTION; RESISTANCE BLOOD VESSEL; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOCAL GLOMERULOSCLEROSIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; SHEEP; TRANSCRIPTION INITIATION; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD UREA NITROGEN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PODOCYTES; PROTEINURIA; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; REFERENCE VALUES; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; SHEEP; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84934779880     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013090968     Document Type: Article

References (28)

1. Bray SJ: Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689, 2006
2. Vooijs M, Schroeter EH, Pan Y, Blandford M, Kopan R: Ectodomain shedding and intramembrane cleavage of mammalian Notch proteins is not regulated through oligomerization. J Biol Chem 279: 50864-50873, 2004
3. Guruharsha KG, Kankel MW, Artavanis-Tsakonas S: The Notch signalling system: Recent insights into the complexity of a conserved pathway. Nat Rev Genet 13: 654-666, 2012
4. Lardelli M, Dahlstrand J, Lendahl U: The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev 46: 123-136, 1994
5. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, RuchouxMM,Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E: Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383: 707-710, 1996
6. Bielesz B, Sirin Y, Si H, Niranjan T, Gruenwald A, Ahn S, Kato H, Pullman J, GesslerM, Haase VH, Susztak K: Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 120: 4040-4054, 2010
7. Niranjan T, Bielesz B, Gruenwald A, Ponda MP, Kopp JB, Thomas DB, Susztak K: The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat Med 14: 290-298, 2008
8. JeongHW, Jeon US, Koo BK, KimWY, ImSK, Shin J, Cho Y, KimJ, Kong YY: Inactivation of Notch signaling in the renal collecting duct causes nephrogenic diabetes insipidus in mice. J Clin Invest 119: 3290-3300, 2009
9. Lasagni L, Ballerini L, AngelottiML, Parente E, Sagrinati C,Mazzinghi B, Peired A, Ronconi E, Becherucci F, Bani D, GacciM, CariniM, Lazzeri E, Romagnani P: Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells 28: 1674-1685, 2010
10. BoulosN,Helle F,Dussaule JC, Placier S,Milliez P,Djudjaj S,GuerrotD, Joutel A, Ronco P, Boffa JJ, Chatziantoniou C: Notch3 is essential for regulation of the renal vascular tone. Hypertension 57: 1176-1182, 2011
11. Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, Boor P, KerrochM, Hanssen L, Brandt S, Dittrich A,Ostendorf T, Floege J, Zhu C, Lindenmeyer M, Cohen CD, Mertens PR: Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol 228: 286-299, 2012
12. Brähler S, Ising C, Hagmann H, Rasmus M, Hoehne M, Kurschat C, Kisner T, Goebel H, Shankland S, Addicks K, Thaiss F, Schermer B, Pasparakis M, Benzing T, Brinkkoetter PT: Intrinsic proinflammatory signaling in podocytes contributes to podocyte damage and prolonged proteinuria. Am J Physiol Renal Physiol 303: F1473-F1485, 2012
13. Sakai N,Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Takeda S, Kida H, Kobayashi K, Mukaida N, Matsushima K, Yokoyama H: p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 17: 998-1004, 2002
14. Le HirM, Keller C, Eschmann V, Hähnel B, Hosser H, Kriz W: Podocyte bridges between the tuft and Bowman's capsule: An early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 12: 2060-2071, 2001
15. van Roeyen CR, Eitner F, Boor P, MoellerMJ, Raffetseder U, Hanssen L, Bücher E, Villa L, Banas MC, Hudkins KL, Alpers CE, Ostendorf T, Floege J: Induction of progressive glomerulonephritis by podocytespecific overexpression of platelet-derived growth factor-D. Kidney Int 80: 1292-1305, 2011
16. Bollée G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL: Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 17: 1242-1250, 2011
17. Laouari D, BurtinM, Phelep A, Martino C, Pillebout E, Montagutelli X, Friedlander G, Terzi F: TGF-alpha mediates genetic susceptibility to chronic kidney disease. J Am Soc Nephrol 22: 327-335, 2011
18. Konishi J, Yi F,Chen X, Vo H,CarboneDP, Dang TP:Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. Oncogene 29: 589-596, 2010
19. Jin S, Hansson EM, Tikka S, Lanner F, Sahlgren C, Farnebo F, Baumann M, Kalimo H, Lendahl U: Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circ Res 102: 1483-1491, 2008
20. Ophascharoensuk V, PippinJW,Gordon KL, Shankland SJ, CouserWG, Johnson RJ: Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 54: 416-425, 1998
21. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ: Inducible rodentmodels of acquired podocyte diseases. Am J Physiol Renal Physiol 296: F213-F229, 2009
22. Morga E, Mouad-Amazzal L, Felten P, Heurtaux T, Moro M, Michelucci A, Gabel S, Grandbarbe L, Heuschling P: Jagged1 regulates the activation of astrocytes via modulation of NFkappaB and JAK/STAT/SOCS pathways. Glia 57: 1741-1753, 2009
23. Barbarulo A, Grazioli P, Campese AF, Bellavia D, Di Mario G, Pelullo M, Ciuffetta A, Colantoni S, Vacca A, Frati L, Gulino A, Felli MP, Screpanti I: Notch3 and canonical NF-kappaB signaling pathways cooperatively regulate Foxp3 transcription. J Immunol 186: 6199-6206, 2011
24. Kumar V, Palermo R, Talora C, Campese AF, Checquolo S, Bellavia D, Tottone L, Testa G, Miele E, Indraccolo S, Amadori A, Ferretti E, Gulino A, Vacca A, Screpanti I: Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia [published online ahead of print April 14, 2014]. Leukemia doi:10.1038/ leu.2014.133
25. Raffetseder U, Rauen T, Boor P, Ostendorf T, Hanssen L, Floege J, En-Nia A, Djudjaj S, Frye BC, Mertens PR: Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling. Nephron, Exp Nephrol 118: e100-e108, 2011
26. Debeb BG, Cohen EN, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, CristofanilliM, Buchholz TA,WoodwardWA: Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res Treat 134: 495-510, 2012
27. Mesnard L, Keller AC, Michel ML, Vandermeersch S, Rafat C, Letavernier E, Tillet Y, Rondeau E, Leite-de-Moraes MC: Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol 20: 1282-1292, 2009
28. Schiwek D, EndlichN, Holzman L, Holthöfer H, KrizW, Endlich K: Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines. Kidney Int 66: 91-101, 2004